FB Bancorp, Inc. /MD/FBLA

Fidelity Bank’s latest 10-Q (period ending 31 March 2026) shows net income of $119,000 on revenues of $18.7 million, producing a headline EPS of $0.01, diluted, for the quarter. Assets stand at $1.27 billion while liabilities sit at $967.3 million, leaving shareholders with $297.7 million of equity. Cash and cash equivalents total $46.2 million, and operating cash flow for the quarter came in at $12.7 million, with just $82,000 spent on property and equipment. The 11-K filing notes that the bank’s website still features the Louisiana Dental Association partnership splash page, a reminder that the brand leans into niche verticals even as the balance sheet remains stubbornly regional.

Fidelity Bank describes itself as providing ‘personalised banking solutions’ for dentists and small businesses, touting mobile wallets, surcharge-free ATMs, and online statements. The public site shows smiling dentists and cheerful entrepreneurs, but the SEC filings quietly reveal a company whose growth in capitalised software costs-$82,000 this quarter-barely registers against the $12.7 million of operating cash flow. The bank’s business services page promises simplicity, yet the 8-K filed on 22 June 2026 focuses on board refreshment rather than balance-sheet refreshment, as if a new director will somehow conjure up the capital to close the gap between the brand’s glossy promises and the bank’s actual economics.

The 11-K also lists five directors and notes that the board has adopted a new insider-trading policy, dated 18 May 2026. Shareholders, however, are still left staring at a diluted EPS of $0.01 and a cash pile that wouldn’t fund a statewide ATM rollout. The bank’s healthcare banking page still features a Louisiana Dental Association logo and a stock image of a dentist with a stethoscope draped around a neck, as if the visual cue alone can make up for a return on equity that wouldn’t raise an eyebrow in a credit-union AGM.

For context, the bank’s product pages-healthcare banking, business services, mobile wallet, online statements, and surcharge-free ATMs-are all hosted on the same template, suggesting a coordinated brand push rather than a product-led transformation. The site’s visuals feel stuck in 2023, while the 10-Q tells a quieter story of a regional bank still learning how to turn its deposit base into sustainable profit. The gap between the polished pitch and the filed numbers is not a gap at all; it’s a chasm.

What changed this week: Fidelity Bank filed an 8-K on 22 June 2026 announcing the appointment of a new director, stating the board believes the addition strengthens governance. The 11-K filed on 29 June 2026 confirms the insider-trading policy update and outlines the bank’s capitalised software development costs, which grew by $82,000 in the quarter. The 10-Q for the quarter ending 31 March 2026 remains the most recent public financial update. There is no evidence of a capital raise, dividend, or share buyback in the supplied filings.

What we still don’t know: Fidelity Bank has not filed an updated 10-Q for the quarter ending 30 June 2026, so we have no view on the latest revenue, net income, or cash-flow trends. The bank’s website does not disclose customer numbers, loan growth, or deposit growth, so we cannot assess whether the brand’s niche positioning in healthcare or surcharge-free ATMs is translating into measurable scale. The 13G filed on 18 May 2026 shows a passive investor holding less than 5% and does not name the beneficial owner, so we have no insight into potential activist pressure or governance influence beyond the board’s own statements. The evidence does not include any customer testimonials, NPS scores, or independent reviews, so the ‘personalised banking’ claim remains untested beyond the bank’s own marketing copy.

Where to look next: If Fidelity Bank files a 10-Q for the quarter ending 30 June 2026, watch for trends in net interest margin, fee income, and operating expenses. A sustained improvement in EPS above $0.05 would signal a genuine inflection, while any further dilution or capitalised cost growth above $200,000 per quarter would raise questions about the return on those investments. Keep an eye on the 8-K pipeline for board changes or policy updates that hint at strategic direction, and check the product pages for evidence of new features or integrations that might close the visual-polish versus filed-reality gap.